Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Serina Therapeutics (SER) Divestments (2018 - 2021)

Serina Therapeutics (SER) has disclosed Divestments for 3 consecutive years, with $516000.0 as the latest value for Q2 2021.

  • Quarterly Divestments changed N/A to $516000.0 in Q2 2021 from the year-ago period, while the trailing twelve-month figure was $466000.0 through Dec 2021, changed N/A year-over-year, with the annual reading at $466000.0 for FY2021, N/A changed from the prior year.
  • Divestments hit $516000.0 in Q2 2021 for Serina Therapeutics, up from -$50000.0 in the prior quarter.
  • In the past five years, Divestments ranged from a high of $3.2 million in Q1 2018 to a low of -$50000.0 in Q1 2021.
  • Historically, Divestments has averaged $939500.0 across 3 years, with a median of $296500.0 in 2019.